Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Urbanization drives cross-taxon declines in abundance and diversity at multiple spatial scales.

Piano E, Souffreau C, Merckx T, Baardsen LF, Backeljau T, Bonte D, Brans KI, Cours M, Dahirel M, Debortoli N, Decaestecker E, De Wolf K, Engelen JMT, Fontaneto D, Gianuca AT, Govaert L, Hanashiro FTT, Higuti J, Lens L, Martens K, Matheve H, Matthysen E, Pinseel E, Sablon R, Schön I, Stoks R, Van Doninck K, Van Dyck H, Vanormelingen P, Van Wichelen J, Vyverman W, De Meester L, Hendrickx F.

Glob Chang Biol. 2019 Nov 22. doi: 10.1111/gcb.14934. [Epub ahead of print]

PMID:
31755626
2.

Evolution at two time frames: Polymorphisms from an ancient singular divergence event fuel contemporary parallel evolution.

Van Belleghem SM, Vangestel C, De Wolf K, De Corte Z, Möst M, Rastas P, De Meester L, Hendrickx F.

PLoS Genet. 2018 Nov 13;14(11):e1007796. doi: 10.1371/journal.pgen.1007796. eCollection 2018 Nov.

3.

Body-size shifts in aquatic and terrestrial urban communities.

Merckx T, Souffreau C, Kaiser A, Baardsen LF, Backeljau T, Bonte D, Brans KI, Cours M, Dahirel M, Debortoli N, De Wolf K, Engelen JMT, Fontaneto D, Gianuca AT, Govaert L, Hendrickx F, Higuti J, Lens L, Martens K, Matheve H, Matthysen E, Piano E, Sablon R, Schön I, Van Doninck K, De Meester L, Van Dyck H.

Nature. 2018 Jun;558(7708):113-116. doi: 10.1038/s41586-018-0140-0. Epub 2018 May 23.

4.

Phase 1 Dose Escalation Trial of Ipilimumab and Stereotactic Body Radiation Therapy in Metastatic Melanoma.

Sundahl N, De Wolf K, Kruse V, Meireson A, Reynders D, Goetghebeur E, Van Gele M, Speeckaert R, Hennart B, Brochez L, Ost P.

Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):906-915. doi: 10.1016/j.ijrobp.2017.11.029. Epub 2017 Nov 24.

PMID:
29485070
5.

Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial.

De Wolf K, Rottey S, Vermaelen K, Decaestecker K, Sundahl N, De Lobel L, Goetghebeur E, De Meerleer G, Lumen N, Fonteyne V, De Maeseneer D, Ost P.

Radiat Oncol. 2017 Sep 22;12(1):157. doi: 10.1186/s13014-017-0893-x.

6.

A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response.

Sundahl N, De Wolf K, Rottey S, Decaestecker K, De Maeseneer D, Meireson A, Goetghebeur E, Fonteyne V, Verbeke S, De Visschere P, Reynders D, Van Gele M, Brochez L, Ost P.

J Transl Med. 2017 Jun 29;15(1):150. doi: 10.1186/s12967-017-1251-3.

7.

A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic response.

De Wolf K, Kruse V, Sundahl N, van Gele M, Chevolet I, Speeckaert R, Brochez L, Ost P.

J Transl Med. 2017 Jan 31;15(1):21. doi: 10.1186/s12967-017-1123-x.

8.

Urbanization drives community shifts towards thermophilic and dispersive species at local and landscape scales.

Piano E, De Wolf K, Bona F, Bonte D, Bowler DE, Isaia M, Lens L, Merckx T, Mertens D, van Kerckvoorde M, De Meester L, Hendrickx F.

Glob Chang Biol. 2017 Jul;23(7):2554-2564. doi: 10.1111/gcb.13606. Epub 2017 Jan 18.

9.

Variations in target volume definition and dose to normal tissue using anatomic versus biological imaging (18 F-FDG-PET) in the treatment of bone metastases: results from a 3-arm randomized phase II trial.

Berwouts D, De Wolf K, De Neve W, Olteanu LA, Lambert B, Speleers B, Goethals I, Madani I, Ost P.

J Med Imaging Radiat Oncol. 2017 Feb;61(1):124-132. doi: 10.1111/1754-9485.12507. Epub 2016 Aug 16.

PMID:
27527354
10.

Behavioral adaptations imply a direct link between ecological specialization and reproductive isolation in a sympatrically diverging ground beetle.

Van Belleghem SM, De Wolf K, Hendrickx F.

Evolution. 2016 Aug;70(8):1904-12. doi: 10.1111/evo.12998. Epub 2016 Jul 27.

PMID:
27405686
11.

The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy.

De Wolf K, Vermaelen K, De Meerleer G, Lambrecht BN, Ost P.

Oncoimmunology. 2015 May 27;4(10):e1042198. eCollection 2015 Oct. Review.

12.

Biological 18[F]-FDG-PET image-guided dose painting by numbers for painful uncomplicated bone metastases: A 3-arm randomized phase II trial.

Berwouts D, De Wolf K, Lambert B, Bultijnck R, De Neve W, De Lobel L, Jans L, Goetghebeur E, Speleers B, Olteanu LA, Madani I, Goethals I, Ost P.

Radiother Oncol. 2015 May;115(2):272-8. doi: 10.1016/j.radonc.2015.04.022. Epub 2015 May 14.

PMID:
25981049
13.

Use of the bromine isotope ratio in HPLC-ICP-MS and HPLC-ESI-MS analysis of a new drug in development.

Cuyckens F, Balcaen LI, De Wolf K, De Samber B, Van Looveren C, Hurkmans R, Vanhaecke F.

Anal Bioanal Chem. 2008 Apr;390(7):1717-29. doi: 10.1007/s00216-007-1761-6. Epub 2008 Jan 3.

PMID:
18172622
14.

Hyphenation of reverse-phase HPLC and ICP-MS for metabolite profiling--application to a novel antituberculosis compound as a case study.

Balcaen LI, De Samber B, De Wolf K, Cuyckens F, Vanhaecke F.

Anal Bioanal Chem. 2007 Oct;389(3):777-86. Epub 2007 May 4.

PMID:
17479254
15.

Netherton's syndrome: a severe neonatal disease. A case report.

De Wolf K, Ferster A, Sass U, André J, Stene JJ, Song M.

Dermatology. 1996;192(4):400-2.

PMID:
8864392
16.

A particular subtype of ichthyosis congenita type III. Clinical, light, and electron microscopic features.

de Wolf K, Gourdain JM, Dobbeleer GD, Song M.

Am J Dermatopathol. 1995 Dec;17(6):606-11.

PMID:
8599478
17.

Dermatologic and systemic manifestations of syphilis.

Goens JL, Janniger CK, De Wolf K.

Am Fam Physician. 1994 Oct;50(5):1013-20. Review.

PMID:
7942400
18.

Mucocutaneous manifestations of chancroid, lymphogranuloma venereum and granuloma inguinale.

Goens JL, Schwartz RA, De Wolf K.

Am Fam Physician. 1994 Feb 1;49(2):415-8, 423-5. Review.

PMID:
8304262

Supplemental Content

Loading ...
Support Center